))
The Lancet Infectious Diseases is a monthly journal, renowned for the publication of high-quality peer-reviewed reviews and analysis from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.
…
continue reading
Saleha Hassan, Senior Editor at The Lancet Infectious Diseases, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from polio eradication in Africa to COVID-19 vaccines in Hong Kong, the treatment of early syphilis in adults to Mpox in the UK, and more.
…
continue reading
1
In Conversation with Steven Tong and Joshua Davis
25:00
25:00
Play later
Play later
Lists
Like
Liked
25:00
Professors Steven Tong and Joshua Davis discuss all aspects of adaptive platform trials including advantages, disadvantages, differences from conventional trials, and tips for setting up and assessing them.By The Lancet
…
continue reading
1
In Conversation with Steven Tong and Joshua Davis on adaptive platform trials
25:48
25:48
Play later
Play later
Lists
Like
Liked
25:48
Professors Steven Tong and Joshua Davis discuss all aspects of adaptive platform trials including advantages, disadvantages, differences from conventional trials, and tips for setting up and assessing them. They also highlight several adaptive platform trials currently in the pipeline that could influence infectious disease clinical practise in the…
…
continue reading
1
In conversation with... Anna Odone, Jesus Rodriguez-Manzano, and Alex Howard
29:12
29:12
Play later
Play later
Lists
Like
Liked
29:12
Series authors discuss their papers on artificial intelligence and infectious diseases intended to support the infectious diseases community in understanding this evolving landscape.By The Lancet
…
continue reading
1
Anna Odone, Jesus Rodriguez-Manzano, and Alex Howard on artificial intelligence and infectious diseases
29:12
29:12
Play later
Play later
Lists
Like
Liked
29:12
Professor Ana Odone, Dr Jesus Rodriguez-Manzano, and Dr Alex Howard discuss their new Series of papers on artificial intelligence and infectious diseases intended to support the infectious diseases community in understanding this evolving landscape and in actively shaping artificial intelligence integration into practice. Read the full Series here:…
…
continue reading
1
In conversation with... Catherine Liu and Joshua Hill
18:27
18:27
Play later
Play later
Lists
Like
Liked
18:27
Drs Catherine Liu and Joshua Hill of the Fred Hutchinson Cancer Center discuss their new Series of papers on the prevention and management of infections in people who are immunocompromised, with a focus on prevention of infections and diagnostic and antimicrobial stewardship.By The Lancet
…
continue reading
1
Catherine Liu and Joshua Hill on prevention and management of infections in people who are immunocompromised
18:27
18:27
Play later
Play later
Lists
Like
Liked
18:27
Drs Catherine Liu and Joshua Hill of the Fred Hutchinson Cancer Center discuss their new Series of papers on the prevention and management of infections in people who are immunocompromised, with a focus on prevention of infections and diagnostic and antimicrobial stewardship. Read the Series papers: https://www.thelancet.com/journals/laninf/article…
…
continue reading
1
In conversation with... Lilian Tina Minja and Norbert Heinrich
29:53
29:53
Play later
Play later
Lists
Like
Liked
29:53
Lilian Tina Minja and Norbert Heinrich discuss the SUDUCO and DECODE trials in The Lancet Infectious Diseases on two new promising TB drugs, sutezolid and delpazolid, respectively. They also discuss the wider implications of the findings of these trials for TB drug development and treatment.By The Lancet
…
continue reading
1
Lilian Tina Minja and Norbert Heinrich on TB drug development
29:53
29:53
Play later
Play later
Lists
Like
Liked
29:53
Lilian Tina Minja and Norbert Heinrich discuss the SUDUCO and DECODE trials in The Lancet Infectious Diseases on two new promising TB drugs, sutezolid and delpazolid, respectively. They also discuss the wider implications of the findings of these trials for TB drug development and treatment. Read the trials: https://www.thelancet.com/journals/lanin…
…
continue reading
1
In conversation with... Leonardo Basso and Juan Pablo Torres
15:27
15:27
Play later
Play later
Lists
Like
Liked
15:27
Leonardo Basso and Juan Pablo Torres discuss their study in The Lancet Infectious Diseases on the effectiveness and impact of the first season of Chile's national immunisation programme with nirsevimab. They discuss the evidence that led to the design and implementation of the programme, its impact on RSV burden and the Chilean health system, and l…
…
continue reading
1
Leonardo Basso and Juan Pablo Torres on the NIRSE-CL study of nirsevimab in Chile
15:27
15:27
Play later
Play later
Lists
Like
Liked
15:27
Leonardo Basso and Juan Pablo Torres discuss their study in The Lancet Infectious Diseases on the effectiveness and impact of the first season of Chile's national immunisation programme with nirsevimab. They discuss the evidence that led to the design and implementation of the programme, its impact on RSV burden and the Chilean health system, and l…
…
continue reading
1
In conversation with... Jan Felix Drexler and Fernando Bozza
35:17
35:17
Play later
Play later
Lists
Like
Liked
35:17
Jan Felix Drexler and Fernando Bozza discuss their recent study published in the journal— “The spatio-temporal ecology of Oropouche virus: a laboratory-based modelling study across Latin America” and its wider implications for Oropouche virus and other arboviruses transmission, expansion, surveillance, and control.…
…
continue reading
1
Jan Felix Drexler and Fernando Bozza on Oropouche virus
35:17
35:17
Play later
Play later
Lists
Like
Liked
35:17
Jan Felix Drexler and Fernando Bozza discuss their recent study published in the journal— “The spatio-temporal ecology of Oropouche virus: a laboratory-based modelling study across Latin America” and its wider implications for Oropouche virus and other arboviruses transmission, expansion, surveillance, and control. Read the full article: https://ww…
…
continue reading
1
In Conversation With… Prasad Kulkarni on a dengue monoclonal antibody
18:53
18:53
Play later
Play later
Lists
Like
Liked
18:53
Prasad Kulkarni discusses a new Phase I trial in The Lancet Infectious Diseases on a dengue monoclonal antibody also known as VIS513 in healthy adults. In addition, he highlights the wider implications of this for dengue control and drug development.By The Lancet
…
continue reading
1
Prasad Kulkarni on dengue monoclonal antibodies
18:53
18:53
Play later
Play later
Lists
Like
Liked
18:53
Prasad Kulkarni discusses a new Phase I trial in The Lancet Infectious Diseases on a dengue monoclonal antibody also known as VIS513 in healthy adults. In addition, he highlights the wider implications of this for dengue control and drug development. Read the full article: https://www.thelancet.com/journals/laninf/article/ S1473-3099(24)00030-6/ful…
…
continue reading
Oriol Mitjà discusses a new trial in The Lancet Infectious Diseases on the use of oral linezolid compared with benzathine penicillin G for the treatment of early syphilis in adults. He also highlights what the trial means for treatment of syphilis.By The Lancet
…
continue reading
1
Oriol Mitjà on treatment of early syphilis in adults
15:25
15:25
Play later
Play later
Lists
Like
Liked
15:25
Oriol Mitjà discusses a new trial in The Lancet Infectious Diseases on the use of oral linezolid compared with benzathine penicillin G for the treatment of early syphilis in adults. He also highlights what the trial means for treatment of syphilis. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00683-7/ful…
…
continue reading
1
In conversation with... Sofia Viegas and Stefan Niemann
24:35
24:35
Play later
Play later
Lists
Like
Liked
24:35
Sofia Viegas and Stefan Niemann discuss a new article in The Lancet Infectious Diseases about emerging bedaquiline resistance in Mozambique and its implications for drug resistant tuberculosis and the fight to end tuberculosis.By The Lancet
…
continue reading
1
Sofia Viegas and Stefan Niemann on emerging bedaquiline resistance in Mozambique
24:35
24:35
Play later
Play later
Lists
Like
Liked
24:35
Sofia Viegas and Stefan Niemann discuss a new article in The Lancet Infectious Diseases about emerging bedaquiline resistance in Mozambique and its implications for drug resistant tuberculosis and the fight to end tuberculosis. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00498-X/fulltext?dgcid=buzzsprou…
…
continue reading
1
In conversation with... Luciano Moreira and Henrik Salje
17:01
17:01
Play later
Play later
Lists
Like
Liked
17:01
Luciano Moreira and Henrik Salje discuss a new article in The Lancet Infectious Diseases describing the use of the Wolbachia bacteria to control the spread of mosquito-borne dengue and chikungunya in Rio de Janeiro, Brazil.By The Lancet
…
continue reading
1
Luciano Moreira and Henrik Salje on Wolbachia control of mosquito-borne infections
17:01
17:01
Play later
Play later
Lists
Like
Liked
17:01
Luciano Moreira and Henrik Salje discuss a new article in The Lancet Infectious Diseases describing the use of the Wolbachia bacteria to control the spread of mosquito-borne dengue and chikungunya in Rio de Janeiro, Brazil. Read the full article: Estimating the effect of the wMel release programme on the incidence of dengue and chikungunya in Rio d…
…
continue reading
1
Richard Maude on malaria chemoprophylaxis in Cambodia
12:44
12:44
Play later
Play later
Lists
Like
Liked
12:44
Richard Maude discusses a new article in The Lancet Infectious Diseases that assesses the efficacy of malaria chemoprophylaxis among forest goers in Cambodia. Read the full article: Antimalarial chemoprophylaxis for forest goers in southeast Asia Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://inst…
…
continue reading
Richard Maude discusses a new article in The Lancet Infectious Diseases that assesses the efficacy of malaria chemoprophylaxis among forest goers in Cambodia.By The Lancet
…
continue reading
1
Ben Cowling on COVID-19 vaccines in Hong Kong
20:58
20:58
Play later
Play later
Lists
Like
Liked
20:58
Ben Cowling discusses a new article in The Lancet Infectious Diseases describing the protection that vaccines are providing against COVID-19 in Hong Kong. Read the full article: Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong Continue this conversation on social! Follow us today at... https…
…
continue reading
Ben Cowling discusses a new article in The Lancet Infectious Diseases describing the protection that vaccines are providing against COVID-19 in Hong Kong.By The Lancet
…
continue reading
Hugh Adler discusses a new article in The Lancet Infectious Diseases describing the management and the clinical features for seven patients with monkeypox hospitalised in the UK between 2018 and 2021. Read the full article: Clinical features and management of human monkeypox: a retrospective observational study in the UK Continue this conversation …
…
continue reading
Hugh Adler discusses a new article in The Lancet Infectious Diseases describing the management and the clinical features for seven patients with monkeypox hospitalised in the UK between 2018 and 2021.By The Lancet
…
continue reading
1
In conversation with... Beate Kampmann, Karen Keddy, and Peter Ghazal
22:16
22:16
Play later
Play later
Lists
Like
Liked
22:16
Prof Beate Kampmann, Dr Karen Keddy, and Prof Peter Ghazal discuss a new cross-journal Series in The Lancet Infectious Diseases and EBioMedicine addressing the potential for and challenge of applying big data to childhood infectious diseases in LMICsBy The Lancet
…
continue reading
1
Beate Kampmann, Karen Keddy, and Peter Ghazal on applying big data to childhood infectious diseases in LMICs
22:16
22:16
Play later
Play later
Lists
Like
Liked
22:16
Prof Beate Kampmann, Dr Karen Keddy, and Prof Peter Ghazal discuss a new cross-journal Series in The Lancet Infectious Diseases and EBioMedicine addressing the potential for and challenge of applying big data to childhood infectious diseases in LMICs. Read the full Series: https://www.thelancet.com/series/big-data-childhood-infections-LMICs Continu…
…
continue reading
1
Laura Cooper and Sam Okiror on polio eradication in Africa
21:34
21:34
Play later
Play later
Lists
Like
Liked
21:34
A new article highlights how changing immunity profiles motivate the need for better responses to outbreaks of polio in Africa. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00453-9/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/th…
…
continue reading
1
In conversation with... Laura Cooper and Sam Okiror
21:34
21:34
Play later
Play later
Lists
Like
Liked
21:34
A new Article in The Lancet Infectious Diseases highlights how changing immunity profiles motivate the need for better responses to outbreaks of polio in Africa.By The Lancet
…
continue reading
Paul Chapman and colleagues presents the results of an innovative trial assessing the safety of vaccinating healthy volunteers with attenuated Necator americanus hookworm larvae.By The Lancet
…
continue reading
Paul Chapman and colleagues presents the results of an innovative trial assessing the safety of vaccinating healthy volunteers with attenuated Necator americanus hookworm larvae. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00153-5/fulltext Continue this conversation on social! Follow us today at... http…
…
continue reading
Josep Llibre discusses a trial on the impact of same-day testing for SARS-CoV-2 infection before a concert on new COVID-19 cases in Ba rcelona, Spain.By The Lancet
…
continue reading
1
Josep Llibre on preventing SARS-CoV-2 transmission at concerts
8:10
8:10
Play later
Play later
Lists
Like
Liked
8:10
Josep Llibre discusses a trial on the impact of same-day testing for SARS-CoV-2 infection before a concert on new COVID-19 cases in Barcelona, Spain. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00268-1/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ ht…
…
continue reading
Yap Boum (MSF) discusses his study done in Cameroon, which developed a promising testing strategy for COVID-19 to optimise the available resource.By The Lancet
…
continue reading
1
Yap Boum on COVID-19 testing in low resource settings
11:21
11:21
Play later
Play later
Lists
Like
Liked
11:21
Yap Boum (MSF) discusses his study done in Cameroon, which developed a promising testing strategy for COVID-19 to optimise the available resources. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00132-8/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ http…
…
continue reading
1
Antimalarial resistance in southeast Asia
13:12
13:12
Play later
Play later
Lists
Like
Liked
13:12
Two studies in The Lancet Infectious Diseases describe how the spread of resistance to both dihydroartemisinin and piperaquine is compromising malaria therapy in South-East AsiaBy The Lancet
…
continue reading
1
Trial in phage therapy for burn infections
29:57
29:57
Play later
Play later
Lists
Like
Liked
29:57
A trial investigates the use of a cocktail of phages for the therapy of infections in patients with burns.By The Lancet
…
continue reading
Editor of The Lancet Infectious Diseases, John McConnell, discusses the 1918 influenza pandemic and the lessons that can be learnt from it with John Oxford and Jeffery Taubenberger.By The Lancet
…
continue reading
1
Bedaquiline and delamanid combination for drug-resistant TB: The Lancet Infectious Diseases: February 13, 2018
15:16
15:16
Play later
Play later
Lists
Like
Liked
15:16
Amir Shroufi discusses the early results assessing the safety and efficacy of the combination of bedaquiline and delamanid against drug-resistant tuberculosis.By The Lancet
…
continue reading
1
MERS and transchromosomic cows: The Lancet Infectious Diseases: January 10, 2018
12:48
12:48
Play later
Play later
Lists
Like
Liked
12:48
John Beigel, an author, and Eddie Sullivan discuss a phase 1 study assessing the safety and tolerability of human antibodies manufactured in transchromosomic cows for treatment of MERS.By The Lancet
…
continue reading
1
PrEP in the UK: The Lancet Infectious Diseases: October 17, 2017
7:07
7:07
Play later
Play later
Lists
Like
Liked
7:07
Valentina Cambiano discusses the cost-effectiveness of pre-exposure prophylaxis medication in the UK.By The Lancet
…
continue reading
1
Polio in Afghanistan: The Lancet Infectious Diseases: August 14, 2017
16:23
16:23
Play later
Play later
Lists
Like
Liked
16:23
Christina Wayman talks to Gillian SteelFisher about polio vaccination in Afghanistan.By The Lancet
…
continue reading
1
Sexually transmitted infections: The Lancet Infectious Diseases: July 9, 2017
7:15
7:15
Play later
Play later
Lists
Like
Liked
7:15
Kit Fairley discusses The Lancet Infectious Diseases' new Commission on sexually transmitted infections.By The Lancet
…
continue reading
1
Infectious diseases in China post-SARS: The Lancet Infectious Diseases: April 12, 2017
23:18
23:18
Play later
Play later
Lists
Like
Liked
23:18
In our latest Chinese-language podcast, Linjuan Li discusses the epidemiology and evolution of infectious diseases in China in the decade since SARS with Lancet editor Helena Wang.By The Lancet
…
continue reading
1
MCR-1 in bacteraemia in China: The Lancet Infectious Diseases: January 27, 2017
20:54
20:54
Play later
Play later
Lists
Like
Liked
20:54
In this special Chinese language podcast, Helena Wang is joined by two authors of papers on MCR-1 to discuss their research.By The Lancet
…
continue reading
1
Inequities in Australian infectious diseases: The Lancet Infectious Diseases: 24 October
7:47
7:47
Play later
Play later
Lists
Like
Liked
7:47
Katherine Gibney discusses her paper on geographic variations and sociodemographic inequities in infectious disease notifications in Australia.By The Lancet
…
continue reading
1
TB Screening: The Lancet Infectious Diseases: March 21, 2016
10:51
10:51
Play later
Play later
Lists
Like
Liked
10:51
Rob Aldridge discusses the prevalence of and risk factors for tuberculosis in UK migrant.By The Lancet
…
continue reading
1
Zika virus in amniotic fluid: The Lancet Infectious Diseases: February 17, 2016
10:21
10:21
Play later
Play later
Lists
Like
Liked
10:21
Ana de Filippis discusses research on how Zika virus has been detected in the amniotic fluid of two pregnant women in Brazil.By The Lancet
…
continue reading
1
Lyme disease: The Lancet Infectious Diseases : February 5, 2016
8:06
8:06
Play later
Play later
Lists
Like
Liked
8:06
Dr. Bobbi Pritt discusses a newly discovered genospecies of Lyme borreliosis.By The Lancet
…
continue reading
